Glioblastoma is the most common and lethal primary malignant brain tumor in adults.
Patients die from recurrent tumors that have become resistant to therapy. New strategies are …

Glioblastoma (GBM) is known to be the most common and lethal primary malignant brain
tumor. Therapies against this neoplasia have a high percentage of failure, associated with …

Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in
humans. It accounts for fifty-two percent of primary brain malignancies in the United States …

Glioblastoma multiforme (GBM) is among the most incurable cancers. GBMs survival rate
has not markedly improved, despite new radical surgery protocols, the introduction of new …

Glioblastoma (GBM) represents the main form of brain tumors in adults, and one of the most
aggressive cancers overall. The treatment of GBM is a combination of surgery (when …

Glioblastoma is the most common malignant primary brain tumor in adults and is almost
invariably fatal. Despite our growing understanding of the various mechanisms underlying …

Glioblastoma (GBM) is the most lethal type of primary brain cancer. Standard care using
chemo-and radio-therapy modestly increases the overall survival of patients; however …

Glioblastoma (GB) is the more frequent and malignant brain tumour. In spite of all efforts, the
median overall survival of GB patients remains approximately 15 months under therapy. The …

Glioma stem cells (GSCs) constitute a slow-dividing, small population within a
heterogeneous glioblastoma. They are able to self-renew, recapitulate a whole tumor, and …

Cellular heterogeneity is a hallmark of advanced cancers and has been ascribed in part to a
population of self-renewing, therapeutically resistant cancer stem cells (CSCs) …